FDA warning letter
Issue date
2 Dec 2022
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
20 Dec 2022
Subject
CGMP/Drug Products/Adulterated
Products & Services
Drugs
Headquarters
Sites
Issue date
Issuing office
Posted date
Subject
Products & Services